Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity Phase I trial consists of two parts. Part A is a single… CISION PRNewswireJune 23, 2026
Press Release New global estimates reveal 258 million children affected by crises as learning losses threaten an entire generation Education Cannot Wait launches new report showing that educational needs are highly… CISION PRNewswireJune 23, 2026
Jinxin Technology Holding Company Announces Plan to Implement ADS Ratio Change SHANGHAI, June 23, 2026 /PRNewswire/ — Jinxin Technology Holding Company ("Jinxin" or… CISION PRNewswireJune 23, 2026
CLPS Incorporation to Present at the Investor Summit Virtual Conference HONG KONG, June 23, 2026 /PRNewswire/ — CLPS Incorporation (the "Company" or… CISION PRNewswireJune 23, 2026
ChinaMarket has embarked on a global journey The Container Arrived. The Real Test Had Just Begun. LINYI, China, June… CISION PRNewswireJune 23, 2026
YeahPay Accelerates Global Expansion, Empowering Merchants' Full Business Lifecycle with "Payment + AI" HONG KONG, June 23, 2026 /PRNewswire/ — YeahPay, an overseas payment brand… CISION PRNewswireJune 23, 2026
Press Release Delegation of China-ASEAN Youth Culture and Heritage Tour Visits Guilin to Explore Northern Guangxi's Cultural Heritage and Build Youth Friendship GUILIN, China, June 23, 2026 /PRNewswire/ — To further deepen cultural exchanges… CISION PRNewswireJune 23, 2026
Press Release electronica Shanghai 2026: High-quality Industrial Enterprises Gather at this Can't-miss Electronics Event ! SHANGHAI, June 23, 2026 /PRNewswire/ — electronica Shanghai 2026 will take place… CISION PRNewswireJune 23, 2026
